|
D80.9 Immunodeficiency with predominantly antibody defects, unspecified |
|
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis |
|
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
|
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
|
D81.30 Adenosine deaminase deficiency, unspecified |
|
D81.31 Severe combined immunodeficiency due to adenosine deaminase deficiency |
|
D81.32 Adenosine deaminase 2 deficiency |
|
D81.39 Other adenosine deaminase deficiency |
|
D81.4 Nezelof's syndrome |
|
D81.5 Purine nucleoside phosphorylase [PNP] deficiency |
|
D81.6 Major histocompatibility complex class I deficiency |
|
D81.7 Major histocompatibility complex class II deficiency |
|
D81.810 Biotinidase deficiency |
|
D81.818 Other biotin-dependent carboxylase deficiency |
|
D81.819 Biotin-dependent carboxylase deficiency, unspecified |
|
D81.89 Other combined immunodeficiencies |
|
D81.9 Combined immunodeficiency, unspecified |
|
D82.0 Wiskott-Aldrich syndrome |
|
D82.1 Di George's syndrome |
|
D82.2 Immunodeficiency with short-limbed stature |
|
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus |
|
D82.4 Hyperimmunoglobulin E [IgE] syndrome |
|
D82.8 Immunodeficiency associated with other specified major defects |
|
D82.9 Immunodeficiency associated with major defect, unspecified |
|
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
|
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
|
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells |
|
D83.8 Other common variable immunodeficiencies |
|
D83.9 Common variable immunodeficiency, unspecified |
|
D84.0 Lymphocyte function antigen-1 [LFA-1] defect |
|
D84.1 Defects in the complement system |
|
D84.81 Immunodeficiency due to conditions classified elsewhere |
|
D84.821 Immunodeficiency due to drugs |
|
D84.822 Immunodeficiency due to external causes |
|
D84.89 Other immunodeficiencies |
|
D84.9 Immunodeficiency, unspecified |
|
D86.0 Sarcoidosis of lung |
|
D86.1 Sarcoidosis of lymph nodes |
|
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes |
|
D86.3 Sarcoidosis of skin |
|
D86.81 Sarcoid meningitis |
|
D86.82 Multiple cranial nerve palsies in sarcoidosis |
|
D86.83 Sarcoid iridocyclitis |
|
D86.84 Sarcoid pyelonephritis |
|
D86.85 Sarcoid myocarditis |
|
D86.86 Sarcoid arthropathy |
|
D86.87 Sarcoid myositis |
|
D86.89 Sarcoidosis of other sites |
|
D86.9 Sarcoidosis, unspecified |
|
D89.0 Polyclonal hypergammaglobulinemia |
|
D89.1 Cryoglobulinemia |
|
D89.2 Hypergammaglobulinemia, unspecified |
|
D89.3 Immune reconstitution syndrome |
|
D89.40 Mast cell activation, unspecified |
|
D89.41 Monoclonal mast cell activation syndrome |
|
D89.42 Idiopathic mast cell activation syndrome |
|
D89.43 Secondary mast cell activation |
|
D89.44 Hereditary alpha tryptasemia |
|
D89.49 Other mast cell activation disorder |
|
D89.810 Acute graft-versus-host disease |
|
D89.811 Chronic graft-versus-host disease |
|
D89.812 Acute on chronic graft-versus-host disease |
|
D89.813 Graft-versus-host disease, unspecified |
|
D89.82 Autoimmune lymphoproliferative syndrome [ALPS] |
|
D89.831 Cytokine release syndrome, grade 1 |
|
D89.832 Cytokine release syndrome, grade 2 |
|
D89.833 Cytokine release syndrome, grade 3 |
|
D89.834 Cytokine release syndrome, grade 4 |
|
D89.835 Cytokine release syndrome, grade 5 |
|
D89.839 Cytokine release syndrome, grade unspecified |
|
D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified |
|
D89.9 Disorder involving the immune mechanism, unspecified |
|
D59.30 Hemolytic-uremic syndrome, unspecified |
|
D59.31 Infection-associated hemolytic-uremic syndrome |
|
D59.32 Hereditary hemolytic-uremic syndrome |
|
D59.39 Other hemolytic-uremic syndrome |
|
D68.00 Von Willebrand disease, unspecified |
|
D68.01 Von Willebrand disease, type 1 |
|
D68.020 Von Willebrand disease, type 2A |
|
D68.021 Von Willebrand disease, type 2B |
|
D68.022 Von Willebrand disease, type 2M |
|
D68.023 Von Willebrand disease, type 2N |
|
D68.029 Von Willebrand disease, type 2, unspecified |
|
D68.03 Von Willebrand disease, type 3 |
|
D68.04 Acquired von Willebrand disease |
|
D68.09 Other von Willebrand disease |
|
D75.821 Non-immune heparin-induced thrombocytopenia |
|
D75.822 Immune-mediated heparin-induced thrombocytopenia |
|
D75.828 Other heparin-induced thrombocytopenia syndrome |
|
D75.829 Heparin-induced thrombocytopenia, unspecified |
|
D75.84 Other platelet-activating anti-PF4 disorders |
|
D81.82 Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
|
E00.0 Congenital iodine-deficiency syndrome, neurological type |
|
E00.1 Congenital iodine-deficiency syndrome, myxedematous type |
|
E00.2 Congenital iodine-deficiency syndrome, mixed type |
|
E00.9 Congenital iodine-deficiency syndrome, unspecified |
|
E01.0 Iodine-deficiency related diffuse (endemic) goiter |
|
E01.1 Iodine-deficiency related multinodular (endemic) goiter |
|
E01.2 Iodine-deficiency related (endemic) goiter, unspecified |
|
E01.8 Other iodine-deficiency related thyroid disorders and allied conditions |
